Ternant D - Search Results

1

Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.

Lioger B, Edupuganti SR, Mulleman D, Passot C, Desvignes C, Bejan-Angoulvant T, Thibault G, Gouilleux-Gruart V, Mélet J, Paintaud G, Ternant D. Lioger B, et al. Among authors: ternant d. Br J Clin Pharmacol. 2017 Aug;83(8):1773-1781. doi: 10.1111/bcp.13270. Epub 2017 Apr 12. Br J Clin Pharmacol. 2017. PMID: 28230269 Free PMC article.

2

Pharmacokinetics and concentration-effect relationships of therapeutic monoclonal antibodies and fusion proteins.

Ternant D, Paintaud G. Ternant D, et al. Expert Opin Biol Ther. 2005 Sep;5 Suppl 1:S37-47. doi: 10.1517/14712598.5.1.s37. Expert Opin Biol Ther. 2005. PMID: 16187939 Review.

3

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of infliximab.

Ternant D, Mulleman D, Degenne D, Willot S, Guillaumin JM, Watier H, Goupille P, Paintaud G. Ternant D, et al. Ther Drug Monit. 2006 Apr;28(2):169-74. doi: 10.1097/01.ftd.0000189901.08684.4b. Ther Drug Monit. 2006. PMID: 16628126 Clinical Trial.

4

Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgammaRIIIa genetic polymorphism.

Ternant D, Büchler M, Bénéton M, Alván G, Ohresser M, Touchard G, Hurault de Ligny B, Toupance O, Watier H, Lebranchu Y, Paintaud G. Ternant D, et al. Br J Clin Pharmacol. 2008 Jan;65(1):60-8. doi: 10.1111/j.1365-2125.2007.02967.x. Epub 2007 Jul 4. Br J Clin Pharmacol. 2008. PMID: 17610526 Free PMC article.

5

Pharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.

Ehrmann S, Mercier E, Vecellio L, Ternant D, Paintaud G, Dequin PF. Ehrmann S, et al. Among authors: ternant d. Intensive Care Med. 2008 Apr;34(4):755-62. doi: 10.1007/s00134-007-0935-1. Epub 2007 Nov 29. Intensive Care Med. 2008. PMID: 18046534 Clinical Trial.

6

Fc gamma RIIIa expression is not increased on natural killer cells expressing the Fc gamma RIIIa-158V allotype.

Congy-Jolivet N, Bolzec A, Ternant D, Ohresser M, Watier H, Thibault G. Congy-Jolivet N, et al. Among authors: ternant d. Cancer Res. 2008 Feb 15;68(4):976-80. doi: 10.1158/0008-5472.CAN-07-6523. Cancer Res. 2008. PMID: 18281470

7

Infliximab pharmacokinetics in inflammatory bowel disease patients.

Ternant D, Aubourg A, Magdelaine-Beuzelin C, Degenne D, Watier H, Picon L, Paintaud G. Ternant D, et al. Ther Drug Monit. 2008 Aug;30(4):523-9. doi: 10.1097/FTD.0b013e318180e300. Ther Drug Monit. 2008. PMID: 18641542

8

Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.

Daydé D, Ternant D, Ohresser M, Lerondel S, Pesnel S, Watier H, Le Pape A, Bardos P, Paintaud G, Cartron G. Daydé D, et al. Among authors: ternant d. Blood. 2009 Apr 16;113(16):3765-72. doi: 10.1182/blood-2008-08-175125. Epub 2008 Nov 24. Blood. 2009. PMID: 19029438 Free article.

9

[Monoclonals antibodies: a recent and major therapeutic advance].

Paintaud G, Lejarre F, Ternant D, Goupille P, Watier H. Paintaud G, et al. Among authors: ternant d. Therapie. 2009 Jan-Feb;64(1):1-7. doi: 10.2515/therapie/2009008. Epub 2009 May 26. Therapie. 2009. PMID: 19463247 Review. French.

10

An enzyme-linked immunosorbent assay for therapeutic drug monitoring of cetuximab.

Cézé N, Ternant D, Piller F, Degenne D, Azzopardi N, Dorval E, Watier H, Lecomte T, Paintaud G. Cézé N, et al. Among authors: ternant d. Ther Drug Monit. 2009 Oct;31(5):597-601. doi: 10.1097/FTD.0b013e3181b33da3. Ther Drug Monit. 2009. PMID: 19730278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters